A subpopulation of CD163-positive macrophages is classically activated in psoriasis

Journal of Investigative Dermatology

Volumn 130, Issue 10, 2010, Pages 2412-2422

  Fuentes Duculan, Judilyn ^a   Suárez Farĩas, Mayte ^a   Zaba, Lisa C ^a   Nograles, Kristine E ^a   Pierson, Katherine C ^a   Mitsui, Hiroshi ^a   Pensabene, Cara A ^a   Kzhyshkowska, Julia ^b,c   Krueger, James G ^a   Lowes, Michelle A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD209 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CELL PROTEIN; CXCL9 CHEMOKINE; HLA DR ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 23P19; LECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MANNOSE RECEPTOR; PROTEIN MARCO; PROTEIN RFD7; RECEPTOR PROTEIN; STABILIN 1; STAT1 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; CXCL9 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOCYTE ANTIGEN; MYXOVIRUS RESISTANCE PROTEIN; STAT1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PSORIASIS; BIOPSY; CELL CULTURE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; BIOPSY; CELLS, CULTURED; CHEMOKINE CXCL9; DENDRITIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GTP-BINDING PROTEINS; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MYXOVIRUS RESISTANCE PROTEINS; PSORIASIS; RECEPTORS, CELL SURFACE; STAT1 TRANSCRIPTION FACTOR;

EID: 77956878373     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.165     Document Type: Article

References (50)

1. Arredouani MS, Palecanda A, Koziel H et al. (2005) MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol 175:6058-6064
2. Bryant P, Ploegh H (2004) Class II MHC peptide loading by the professionals. Curr Opin Immunol 16:96-102
3. Casanova JL, Abel L (2009) Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 206:1839-1843
4. Chamian F, Lowes MA, Lin SL et al. (2005) Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-2080
5. Djemadji-Oudjiel N, Goerdt S, Kodelja V et al. (1996) Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/\-, 25F9-) in psoriatic dermis. Arch Dermatol Res 288:757-764
6. Eskelinen EL (2006) Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 27:495-502
7. Fabriek BO, Dijkstra CD, van den Berg TK (2005) The macrophage scavenger receptor CD163. Immunobiology 210:153-160
8. Gisondi P, Targher G, Zoppini G et al. (2009) Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 51:758-764
9. Goerdt S, Politz O, Schledzewski K et al. (1999) Alternative versus classical activation of macrophages. Pathobiology 67:222-226
10. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35
11. Gratchev A, Kzhyshkowska J, Kothe K et al. (2006) Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 211:473-486
12. Gratchev A, Kzhyshkowska J, Utikal J et al. (2005) Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 61:10-17
13. Haider AS, Lowes MA, Suarez-Farinas M et al. (2007) Cellular genomic maps help dissect pathology in human skin disease. J Invest Dermatol 128:606-615
14. Krutzik SR, Tan B, Li H et al. (2005) TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 11:653-660
15. Kryczek I, Bruce AT, Gudjonsson JE et al. (2008) Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181:4733-4741
16. Kzhyshkowska J, Gratchev A, Goerdt S (2006) Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med 10:635-649
17. Kzhyshkowska J, Gratchev A, Martens JH et al. (2004) Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors. J Leukoc Biol 76:1151-1161
18. Lew W, Lee E, Krueger JG (2004) Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. Br J Dermatol 150:668-676
19. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-873
20. Lowes MA, Chamian F, Abello MV et al. (2005) Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 102:19057-19062
21. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-1211
22. Mantovani A, Sica A, Sozzani S et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686
23. Martinez FO, Gordon S, Locati M et al. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303-7311
24. Moestrup SK, Moller HJ (2004) CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 36:347-354
25. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969
26. Nickoloff BJ, Bonish BK, Marble DJ et al. (2006) Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation. J Investig Dermatol Symp Proc 11:16-29
27. Nijsten T, Wakkee M (2009) Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 129:1601-1603
28. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159:1086-1091
29. Ochoa MT, Loncaric A, Krutzik SR et al. (2008) "Dermal dendritic cells" comprise two distinct populations: CD1(+) dendritic cells and CD209(+) macrophages. J Invest Dermatol 128:2225-2231
30. Onofre G, Kolackova M, Jankovicova K et al. (2009) Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove) 52:57-61
31. Pantelidis P, McGrath DS, Southcott AM et al. (2001) Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific. Respir Res 2:365-372
32. Politz O, Gratchev A, McCourt PA et al. (2002) Stabilin-1 and-2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 362:155-164
33. Rottman JB, Smith TL, Ganley KG et al. (2001) Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the patho-genesis of psoriasis vulgaris. Lab Invest 81:335-347
34. Sankala M, Brannstrom A, Schulthess T et al. (2002) Characterization of recombinant soluble macrophage scavenger receptor MARCO. J Biol Chem 277:33378-33385
35. Sanmiguel JC, Olaru F, Li J et al. (2009) Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways. Cell Signal 21:685-694
36. Stout RD, Jiang C, Matta B et al. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenviron-mental influences. J Immunol 175:342-349
37. Suárez-Fariñas M, Lowes MA, Zaba LC, Krueger JG (2010) Evaluation of the psoriasis transcriptome across different studies by Gene Set Enrichment Analysis (GSEA). PLoS ONE 5:e10247
38. Subramanian A, Tamayo P, Mootha VK et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550
39. Suttles J, Stout RD (2009) Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis. Semin Immunol 21:257-264
40. Taams LS, Poulter LW, Rustin MH et al. (1999) Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7. Pathobiology 67:249-252
41. Torocsik D, Bardos H, Nagy L et al. (2005) Identification of factor XIII-A as a marker of alternative macrophage activation. Cell Mol Life Sci 62:2132-2139
42. van den Oord JJ, De Ley M, De Wolf-Peeters C (1995) Distribution of interferon-gamma receptors in normal and psoriatic skin. Pathol Res Pract 191:530-534
43. Wang F, Lee E, Lowes MA et al. (2006) Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects. J Invest Dermatol 126:1590-1599
44. Way KJ, Dinh H, Keene MR et al. (2009) The generation and properties of human macrophage populations from hemopoietic stem cells. J Leukoc Biol 85:766-778
45. Wilson HM, Barker RN, Erwig LP (2009) Macrophages: promising targets for the treatment of atherosclerosis. Curr Vasc Pharmacol 7:234-243
46. Wu K, Yuan J, Lasky LA (1996) Characterization of a novel member of the macrophage mannose receptor type C lectin family. J Biol Chem 271:21323-21330
47. Yawalkar N, Tscharner GG, Hunger RE et al. (2009) Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis. J Dermatol Sci 54:99-105
48. Zaba LC, Cardinale I, Gilleaudeau P et al. (2007a) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-3194
49. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129:79-88
50. Zaba LC, Fuentes-Duculan J, Steinman RM et al. (2007b) Normal human dermis contains distinct populations of CD11cBDCA-1 dendritic cells and CD163FXIIIA macrophages. J Clin Invest 117:2517-2525